熱門資訊> 正文
Hologic 2026年第四季度盈利预览
2026-01-29 06:35
- Hologic (HOLX) is scheduled to announce Q4 earnings results on Thursday, January 29th, after market close.
- The consensus EPS Estimate is $1.10 (-2.7% Y/Y) and the consensus Revenue Estimate is $1.07B (+1.9% Y/Y).
- Over the last 2 years, HOLX has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 5 upward revisions and 0 downward. Revenue estimates have seen 4 upward revisions and 1 downward.
More on Hologic
- Hologic, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Hologic says 2026 CVR is more challenging with stopped shipment of product
- Hologic Non-GAAP EPS of $1.13 beats by $0.03, revenue of $1.05B beats by $20M
- Seeking Alpha’s Quant Rating on Hologic
- Historical earnings data for Hologic
推薦文章
港股周報 | 中國大模型「春節檔」打響！智譜周漲超138%；鉅虧超230億！美團周內重挫超10%
一周財經日曆 | 港美股迎「春節+總統日」雙假期！萬億零售巨頭沃爾瑪將發財報
一周IPO | 賺錢效應持續火熱！年內24只上市新股「0」破發；「圖模融合第一股」海致科技首日飆漲逾242%
從軟件到房地產，美國多板塊陷入AI恐慌拋售潮
Meta計劃為智能眼鏡添加人臉識別技術
危機四伏，市場卻似乎毫不在意
美股機會日報 | 降息預期升溫！美國1月CPI年率創去年5月來新低；淨利、指引雙超預期！應用材料盤前漲超10%
財報前瞻 | 英偉達Q4財報放榜在即！高盛、瑞銀預計將大超預期，兩大關鍵催化將帶來意外驚喜？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
